Insider Shareholders with Direct Ownership of Heron Therapeutics, Inc. (HRTX)
This section provides a comprehensive overview of the insiders with direct ownership of Heron Therapeutics, Inc. (HRTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
HERON THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Craig A Collard
Chief Executive Officer |
267,688 | 1,383 | 314,867 $777,721 | 8 |
Jan 19, 2025
Added 4.2%
|
|
Barry D Quart
Chief Executive Officer |
119,868 | 29,947 | 177,989 $439,632 | 23 |
Jan 13, 2023
Reduced 2.85%
|
|
Ira Duarte
EVP, Chief Financial Officer |
112,997 | 1,122 | 120,580 $297,832 | 7 |
Jan 19, 2025
Added 3.11%
|
|
William P Forbes
EVP, Chief Development Officer |
102,997 | 0 | 106,997 $264,282 | 7 |
Jan 19, 2025
Added 3.49%
|
| 80,930 | 0 | 87,180 $215,334 | 4 |
Jan 30, 2025
Added 17.07%
|
|
| 80,930 | 0 | 87,180 $215,334 | 4 |
Jan 30, 2025
Added 17.07%
|
|
| 83,930 | 1,200 | 84,130 $207,801 | 9 |
Jan 30, 2025
Added 17.58%
|
|
| 83,930 | 1,000 | 83,770 $206,911 | 9 |
Jan 30, 2025
Added 17.65%
|
|
| 69,777 | 0 | 69,777 $172,349 | 3 |
Jan 30, 2025
Added 20.46%
|
|
|
Lisa Peraza
VP, Chief Accounting Officer |
68,087 | 23,439 | 55,907 $138,090 | 29 |
Jan 13, 2024
Reduced 1.33%
|
| 55,829 | 0 | 55,829 $137,897 | 2 |
Jan 30, 2025
Added 24.33%
|
|
|
Stephen Davis
Director |
52,032 | 0 | 52,032 $128,519 | 3 |
Dec 16, 2022
Added 42.58%
|
|
John Poyhonen
President & CCO |
42,309 | 13,804 | 46,648 $115,220 | 23 |
Apr 13, 2023
Reduced 4.13%
|
|
David Leslie Szekeres
EVP, Chief Operating Officer |
50,387 | 20,204 | 33,754 $83,372 | 27 |
Jul 13, 2023
Reduced 5.63%
|
|
Kimberly Manhard
EVP, Drug Development |
54,572 | 26,242 | 28,330 $69,975 | 27 |
Apr 13, 2023
Reduced 4.76%
|